NEXTCURE, INC Available-for-sale Securities, Gross Realized Gains
NEXTCURE, INC (NXTC) reported Available-for-sale Securities, Gross Realized Gains of $54.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGains · last filed 2021-05-06
- NEXTCURE, INC available-for-sale securities, gross realized gains for the quarter ending 2021-03-31 was $54.00K, a 15.63% decline year-over-year.
- NEXTCURE, INC available-for-sale securities, gross realized gains for the quarter ending 2020-12-31 was $0.00.
- NEXTCURE, INC available-for-sale securities, gross realized gains for the quarter ending 2020-09-30 was $3.00K.
- NEXTCURE, INC available-for-sale securities, gross realized gains for the quarter ending 2020-06-30 was $4.00K.
- NEXTCURE, INC available-for-sale securities, gross realized gains for fiscal 2020 was $70.00K.
- NEXTCURE, INC available-for-sale securities, gross realized gains for fiscal 2019 was $0.00.
| Period end | Available-for-sale Securities, Gross Realized Gains 3 month | Available-for-sale Securities, Gross Realized Gains 6 month | Available-for-sale Securities, Gross Realized Gains 9 month | Available-for-sale Securities, Gross Realized Gains 12 month |
|---|---|---|---|---|
| 2021-03-31 | $54.00K 10-Q · filed 2021-05-06 | $54.00K derived: sum of 2 quarters · filed 2021-05-06 | $57.00K derived: sum of 3 quarters · filed 2021-05-06 | $61.00K derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $3.00K derived: sum of 2 quarters · filed 2021-03-04 | $7.00K derived: sum of 3 quarters · filed 2021-03-04 | $70.00K 10-K · filed 2021-03-04 |
| 2020-09-30 | $3.00K 10-Q · filed 2020-11-05 | $7.00K derived: sum of 2 quarters · filed 2020-11-05 | $70.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $4.00K 10-Q · filed 2020-08-06 | $68.00K 10-Q · filed 2020-08-06 | ||
| 2020-03-31 | $64.00K 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |